phloroglucinol has been researched along with Atherosclerotic Parkinsonism in 2 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryu, J | 1 |
| Zhang, R | 1 |
| Hong, BH | 1 |
| Yang, EJ | 1 |
| Kang, KA | 1 |
| Choi, M | 1 |
| Kim, KC | 1 |
| Noh, SJ | 1 |
| Kim, HS | 2 |
| Lee, NH | 1 |
| Hyun, JW | 1 |
| Wang, YD | 1 |
| Bao, XQ | 1 |
| Xu, S | 1 |
| Yu, WW | 1 |
| Cao, SN | 1 |
| Hu, JP | 1 |
| Li, Y | 1 |
| Wang, XL | 1 |
| Zhang, D | 1 |
| Yu, SS | 1 |
2 other studies available for phloroglucinol and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.
Topics: Animals; Antiparkinson Agents; Catalase; Cell Line; Gene Expression; Glutathione Peroxidase; Guanine | 2013 |
A Novel Parkinson's Disease Drug Candidate with Potent Anti-neuroinflammatory Effects through the Src Signaling Pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Ani | 2016 |